Lorbrena
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Lorbrena, covering 2018-11-02 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer [Phase 1, Phase 2]